ELIAS ALHARARI: Open Payments
NPI 1588104541 · FRISCO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$19,778 in 236 payments from 21 companies in 2025. Trend: 2023 $3,213 · 2024 $16,315 · 2025 $19,778
Speaker / faculty: $14,570Food & beverage: $4,142Travel & lodging: $1,066
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 80 | $16,818 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 23 | $510 |
| ABBVIE INC. | 28 | $504 |
| E.R. Squibb & Sons, L.L.C. | 22 | $403 |
| Teva Pharmaceuticals USA, Inc. | 14 | $279 |
| Corium, LLC | 9 | $222 |
| Otsuka America Pharmaceutical, Inc. | 16 | $220 |
| Lundbeck LLC | 11 | $170 |
| Tris Pharma Inc | 6 | $127 |
| Vanda Pharmaceuticals Inc. | 5 | $94 |
Products named: SPRAVATO, CAPLYTA, VRAYLAR, COBENFY, REXULTI, Azstarys, INVEGA SUSTENNA, AUSTEDO XR.
Industry payments across TX — which companies pay providers there.
